These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
298 related items for PubMed ID: 18234905
1. Short-course antibiotic treatment in acute exacerbations of chronic bronchitis and COPD: a meta-analysis of double-blind studies. El Moussaoui R, Roede BM, Speelman P, Bresser P, Prins JM, Bossuyt PM. Thorax; 2008 May; 63(5):415-22. PubMed ID: 18234905 [Abstract] [Full Text] [Related]
2. Short- versus long-course antibiotic therapy for acute pyelonephritis in adolescents and adults: a meta-analysis of randomized controlled trials. Kyriakidou KG, Rafailidis P, Matthaiou DK, Athanasiou S, Falagas ME. Clin Ther; 2008 Oct; 30(10):1859-68. PubMed ID: 19014841 [Abstract] [Full Text] [Related]
3. Short-course therapy of acute bacterial exacerbation of chronic bronchitis: a double-blind, randomized, multicenter comparison of extended-release versus immediate-release clarithromycin. Nalepa P, Dobryniewska M, Busman T, Notario G. Curr Med Res Opin; 2003 Oct; 19(5):411-20. PubMed ID: 13678478 [Abstract] [Full Text] [Related]
4. Comparative efficacy of once daily, 5-day short-course therapy with clarithromycin extended-release versus twice daily, 7-day therapy with clarithromycin immediate-release in acute bacterial exacerbation of chronic bronchitis. Gotfried M, Notario G, Spiller J, Palmer R, Busman T. Curr Med Res Opin; 2005 Feb; 21(2):245-54. PubMed ID: 15801995 [Abstract] [Full Text] [Related]
5. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis. Sobieraj DM, White CM, Coleman CI. Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985 [Abstract] [Full Text] [Related]
6. Short- versus long-duration antimicrobial treatment for exacerbations of chronic bronchitis: a meta-analysis. Falagas ME, Avgeri SG, Matthaiou DK, Dimopoulos G, Siempos II. J Antimicrob Chemother; 2008 Sep; 62(3):442-50. PubMed ID: 18467303 [Abstract] [Full Text] [Related]
7. Double-blind study of OM-85 in patients with chronic bronchitis or mild chronic obstructive pulmonary disease. Solèr M, Mütterlein R, Cozma G, Swiss-German OM-85 Study Group. Respiration; 2007 Sep; 74(1):26-32. PubMed ID: 16772707 [Abstract] [Full Text] [Related]
8. Is co-morbidity taken into account in the antibiotic management of elderly patients with acute bronchitis and COPD exacerbations? Bont J, Hak E, Birkhoff CE, Hoes AW, Verheij TJ. Fam Pract; 2007 Sep; 24(4):317-22. PubMed ID: 17602175 [Abstract] [Full Text] [Related]
9. Prulifloxacin versus levofloxacin in the treatment of severe COPD patients with acute exacerbations of chronic bronchitis. Blasi F, Schaberg T, Centanni S, Del Vecchio A, Rosignoli MT, Dionisio P. Pulm Pharmacol Ther; 2013 Oct; 26(5):609-16. PubMed ID: 23538168 [Abstract] [Full Text] [Related]
10. Short-course fluoroquinolone therapy in exacerbations of chronic bronchitis and COPD. Anzueto A, Miravitlles M. Respir Med; 2010 Oct; 104(10):1396-403. PubMed ID: 20580215 [Abstract] [Full Text] [Related]
11. Identifying patients at risk of late recovery (≥ 8 days) from acute exacerbation of chronic bronchitis and COPD. Anzueto A, Miravitlles M, Ewig S, Legnani D, Heldner S, Stauch K. Respir Med; 2012 Sep; 106(9):1258-67. PubMed ID: 22749710 [Abstract] [Full Text] [Related]
12. Variables associated with recovery from acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease. Miravitlles M, Llor C, Naberan K, Cots JM, Molina J, EFEMAP study group. Respir Med; 2005 Aug; 99(8):955-65. PubMed ID: 15950136 [Abstract] [Full Text] [Related]
13. Characterisation of exacerbations of chronic bronchitis and COPD in Europe: the GIANT study. Miravitlles M, Anzueto A, Ewig S, Legnani D, Stauch K. Ther Adv Respir Dis; 2009 Dec; 3(6):267-77. PubMed ID: 19880426 [Abstract] [Full Text] [Related]
14. Development of a COPD severity score. Wu EQ, Birnbaum HG, Cifaldi M, Kang Y, Mallet D, Colice G. Curr Med Res Opin; 2006 Sep; 22(9):1679-87. PubMed ID: 16968571 [Abstract] [Full Text] [Related]
15. Effect of ELOM-080 on exacerbations and symptoms in COPD patients with a chronic bronchitis phenotype - a post-hoc analysis of a randomized, double-blind, placebo-controlled clinical trial. Beeh KM, Beier J, Candler H, Wittig T. Int J Chron Obstruct Pulmon Dis; 2016 Sep; 11():2877-2884. PubMed ID: 27920515 [Abstract] [Full Text] [Related]
16. Antibiotic treatment and factors influencing short and long term outcomes of acute exacerbations of chronic bronchitis. Wilson R, Jones P, Schaberg T, Arvis P, Duprat-Lomon I, Sagnier PP, MOSAIC Study Group. Thorax; 2006 Apr; 61(4):337-42. PubMed ID: 16449273 [Abstract] [Full Text] [Related]
17. Counting, analysing and reporting exacerbations of COPD in randomised controlled trials. Aaron SD, Fergusson D, Marks GB, Suissa S, Vandemheen KL, Doucette S, Maltais F, Bourbeau JF, Goldstein RS, Balter M, O'Donnell D, Fitzgerald M, Canadian Thoracic Society/Canadian Respiratory Clinical Research Consortium. Thorax; 2008 Feb; 63(2):122-8. PubMed ID: 17702790 [Abstract] [Full Text] [Related]
18. Economic assessment of early initiation of inhaled corticosteroids in chronic obstructive pulmonary disease using propensity score matching. Akazawa M, Biddle AK, Stearns SC. Clin Ther; 2008 Feb; 30 Spec No():1003-16. PubMed ID: 18640475 [Abstract] [Full Text] [Related]
19. Levofloxacin 500 mg once daily versus cefuroxime 250 mg twice daily in patients with acute exacerbations of chronic obstructive bronchitis: clinical efficacy and exacerbation-free interval. Petitpretz P, Choné C, Trémolières F, Investigator Study Group. Int J Antimicrob Agents; 2007 Jul; 30(1):52-9. PubMed ID: 17512704 [Abstract] [Full Text] [Related]
20. Efficacy of short-course antibiotic regimens for community-acquired pneumonia: a meta-analysis. Li JZ, Winston LG, Moore DH, Bent S. Am J Med; 2007 Sep; 120(9):783-90. PubMed ID: 17765048 [Abstract] [Full Text] [Related] Page: [Next] [New Search]